Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Cidara Therapeutics revenue
Cidara Therapeutics's revenue is $49.6 million.
What is Cidara Therapeutics's revenue?
- Cidara Therapeutics's revenue growth from 2019 to 2021 is 137.02%.
- Cidara Therapeutics has 68 employees, and the revenue per employee ratio is $729,000.
- Cidara Therapeutics's peak quarterly revenue was $8.5M in 2024(q1).
- Cidara Therapeutics peak revenue was $49.6M in 2021.
- Cidara Therapeutics annual revenue for 2020 was 12.1M, -42.3% growth from 2019.
- Cidara Therapeutics annual revenue for 2021 was 49.6M, 310.81% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Cidara Therapeutics historical revenue
Cidara Therapeutics's peak revenue was $49.6M in 2021. The peak quarterly revenue was $8.5M in 2024(q1).
Cidara Therapeutics's revenue increased from $20.9m in 2019 to $49.6M currently. That's a 137.02% change in annual revenue.
Cidara Therapeutics annual revenue
Cidara Therapeutics annual revenue over time
| Fiscal year / year | Cidara Therapeutics revenue |
|---|---|
| 2019 | $20.9M |
| 2020 | $12.1M |
| 2021 | $49.6M |
Cidara Therapeutics jobs nearby
Do you work at Cidara Therapeutics?
Is Cidara Therapeutics transparent about its revenue structure?
Cidara Therapeutics financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 68 |
| Date Founded | 2012 |
| Headquarters | San Diego, California |
| Number of Locations | 3 |
| Revenue | $49.6M |
| Net Income | -$29,799,000 |
| Gross Proft | ($1.6M) (2014) |
| PE Ratio | -2.98 |
| Market Capitalization | $126.5M |
| Total Assets | $47,593,000 |
| Ticker | CDTX |
Cidara Therapeutics jobs you might like
Cidara Therapeutics financing
Cidara Therapeutics received early financing of $32.0M on 2014-06-30.
| Series | Round size | Date |
|---|---|---|
| Series A | $32M | 06/2014 |
| Series B | $42M | 02/2015 |
| Post Ipo Debt | $20M | 11/2016 |
| Grant | $6.9M | 03/2017 |
| Post Ipo Equity | $20.2M | 10/2017 |
| Post Ipo Equity | $35M | 10/2021 |
Cidara Therapeutics investors
| Investors | Security type |
|---|---|
| 5 Am Ventures | Series A |
| Frazier Healthcare Partners | Series A |
| InterWest Partners | Series A |
| Aisling Capital | Series A |
| 5 Am Ventures | Series B |
| Frazier Healthcare Partners | Series B |
| Sabby Capital | Series B |
| Perceptive Advisors | Series B |
| venBio Partners | Series B |
| RA Capital Management | Series B |
| Fidelity Investments | Series B |
| Rock Springs Capital | Series B |
| CAM Capital | Series B |
| Aisling Capital | Series B |
| Square 1 Bank | Post Ipo Debt |
| CARB X | Grant |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Cidara Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cidara Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Cidara Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cidara Therapeutics. The data presented on this page does not represent the view of Cidara Therapeutics and its employees or that of Zippia.
Cidara Therapeutics may also be known as or be related to CIDARA THERAPEUTICS INC., Cidara Therapeutics, Cidara Therapeutics Inc and Cidara Therapeutics, Inc.